Botond Z Igyártó

Dr. Botond Z Igyártó

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cell
Verified
Journal Article
Closed access
ESElizabeth M. Steinert
Elizabeth M. Steinert
JSJason M. Schenkel
Jason M. Schenkel
KFKathryn A. Fraser
Kathryn A. Fraser
LBLalit K. Beura
Lalit K. Beura
LMLuke S. Manlove
Luke S. Manlove
DMDavid Masopust
David Masopust

20 November 2021 in iScience
Verified
Journal Article
Open access
SNSonia Ndeupen
Sonia Ndeupen
ZQZhen Qin
Zhen Qin
SJSonya Jacobsen
Sonya Jacobsen
ABAurélie Bouteau
Aurélie Bouteau
HEHenri Estanbouli
Henri Estanbouli
BIBotond Z Igyártó
Botond Z Igyártó
Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new platform used by two leading vaccines against COVID-19. Clinical trials and ongoing vaccinations present with varying degrees of protection levels and side effects. However, the drivers of the reported side effects remain poorly defined. Here we present evidence that Acuitas' LNPs used in preclinical nucleoside-modified mRNA vaccine studies are highly inflammatory in mice. Intradermal and intramuscular injection of these LNPs led to rapid and robust inflammatory responses, characterized by massive neutrophil infiltration, activation of diverse inflammatory pathways, and production of various inflammatory cytokines and chemokines. The same dose of LNP delivered intranasally led to similar inflammatory responses in the lung and resulted in a high mortality rate, with mechanism unresolved. Thus, the mRNA-LNP platforms' potency in supporting the induction of adaptive immune responses and the observed side effects may stem from the LNPs' highly inflammatory nature.

13 January 2012 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
DKDaniel H. Kaplan
Daniel H. Kaplan
BIBotond Z Igyártó
Botond Z Igyártó
AGAnthony A. Gaspari
Anthony A. Gaspari

17 December 2007 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LBLaura S. Bursch
Laura S. Bursch
LWLiangchun Wang
Liangchun Wang
BIBotond Z Igyártó
Botond Z Igyártó
AKAdrien Kissenpfennig
Adrien Kissenpfennig
BMBernard Malissen
Bernard Malissen
KHKristin A. Hogquist
Kristin A. Hogquist
Langerhans cells (LCs) are antigen-presenting cells that reside in the epidermis of the skin and traffic to lymph nodes (LNs). The general role of these cells in skin immune responses is not clear because distinct models of LC depletion resulted in opposite conclusions about their role in contact hypersensitivity (CHS) responses. While comparing these models, we discovered a novel population of LCs that resides in the dermis and does not represent migrating epidermal LCs, as previously thought. Unlike epidermal LCs, dermal Langerin+ dendritic cells (DCs) were radiosensitive and displayed a distinct cell surface phenotype. Dermal Langerin+ DCs migrate from the skin to the LNs after inflammation and in the steady state, and represent the majority of Langerin+ DCs in skin draining LNs. Both epidermal and dermal Langerin+ DCs were depleted by treatment with diphtheria toxin in Lang-DTREGFP knock-in mice. In contrast, transgenic hLang-DTA mice lack epidermal LCs, but have normal numbers of dermal Langerin+ DCs. CHS responses were abrogated upon depletion of both epidermal and dermal LCs, but were unaffected in the absence of only epidermal LCs. This suggests that dermal LCs can mediate CHS and provides an explanation for previous differences observed in the two-model systems.

1 August 2011 in Immunity
Verified
Journal Article
Closed access
BIBotond Z Igyártó
Botond Z Igyártó
KHKrystal Haley
Krystal Haley
DODaniela Ortner
Daniela Ortner
ABAleh Bobr
Aleh Bobr
MGMaryam Gerami-Nejad
Maryam Gerami-Nejad
DKDaniel H. Kaplan
Daniel H. Kaplan

1 October 2011 in Immunity
Verified
Journal Article
Closed access
MPMarion Pepper
Marion Pepper
APAntonio J. Pagán
Antonio J. Pagán
BIBotond Z Igyártó
Botond Z Igyártó
JTJustin J. Taylor
Justin J. Taylor
MJMarc K. Jenkins
Marc K. Jenkins